XML 24 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 56,726,000 $ 48,888,000 [1],[2] $ 61,733,000 [1],[2]
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 48,719,000 38,984,000 [1] 34,580,000 [1]
Stock-based compensation expense 23,901,000 23,041,000 [1] 19,770,000 [1]
Unrealized gain on short term investments (7,696,000) 0 [1] 0 [1]
Unrealized foreign exchange (gain)/loss, net (8,620,000) 1,523,000 [1] (1,001,000) [1]
Deferred income tax (benefit)/expense (625,000) 731,000 [1] (3,384,000) [1]
Impairment charges 20,056,000 0 [1],[2] 0 [1],[2]
Excess tax benefit from stock-based compensation 0 0 [1] (4,326,000) [1]
Change in fair value of earn-out consideration 0 0 [1] (4,060,000) [1]
Allowance for doubtful accounts receivable (573,000) 2,816,000 [1] 0 [1]
Loss from equity-method investment 247,000 0 [1],[2] 0 [1],[2]
Others, net 903,000 252,000 [1] (107,000) [1]
Change in operating assets and liabilities, net of effects of acquisitions:      
Accounts receivable (10,046,000) (20,482,000) [1] (18,062,000) [1]
Prepaid expenses and other current assets (4,509,000) 218,000 [1] (5,421,000) [1]
Accounts payable (360,000) 1,706,000 [1] (2,628,000) [1]
Deferred revenue (4,929,000) (6,625,000) [1] 5,726,000 [1]
Accrued employee costs 1,272,000 6,391,000 [1] 5,304,000 [1]
Accrued expenses and other liabilities (1,084,000) 6,903,000 [1] 9,080,000 [1]
Advance income tax, net (14,147,000) 11,037,000 [1] 437,000 [1]
Other assets (6,800,000) (2,224,000) [1] 4,754,000 [1]
Net cash provided by operating activities [1] 92,435,000 113,159,000 102,395,000
Cash flows from investing activities:      
Purchase of property and equipment (40,437,000) (35,154,000) [1] (25,850,000) [1]
Investment in equity affiliate 0 (3,000,000) [1] 0 [1]
Business acquisition (net of cash acquired) (231,829,000) (23,300,000) [1] (28,666,000) [1]
Purchase of investments (133,434,000) (402,721,000) [1] (182,471,000) [1]
Proceeds from redemption of investments 128,208,000 241,439,000 [1] 182,320,000 [1]
Net cash used for investing activities (277,492,000) (222,736,000) [1] (54,667,000) [1]
Cash flows from financing activities:      
Principal payments on capital lease obligations (152,000) (174,000) [1] (348,000) [1]
Proceeds from borrowings 246,614,000 60,574,000 [1] 0 [1]
Repayments of borrowings (155,209,000) (45,192,000) [1] (25,000,000) [1]
Proceeds from convertible notes 149,000,000 0 [1] 0 [1]
Payment of debt issuance costs (762,000) (790,000) [1] 0 [1]
Acquisition of treasury stock (43,109,000) (43,454,000) [1] (18,203,000) [1]
Proceeds from exercise of stock options 1,397,000 8,561,000 [1] 6,499,000 [1]
Excess tax benefit from stock-based compensation 0 0 [1] 4,326,000 [1]
Net cash provided by/(used for) financing activities 197,779,000 (20,475,000) [1] (32,726,000) [1]
Effect of exchange rate changes on cash, cash equivalents and restricted cash [1] (2,868,000) 3,935,000 (5,122,000)
Net increase/(decrease) in cash, cash equivalents and restricted cash(1) [1] 9,854,000 (126,117,000) 9,880,000
Cash, cash equivalents and restricted cash - beginning of year [1] 94,277,000 220,394,000 210,514,000
Cash, cash equivalents and restricted cash - end of year [1] 104,131,000 94,277,000 220,394,000
Supplemental disclosure of cash flow information:      
Restricted common stock issued for business acquisition 4,080,000 0 [1] 0 [1]
Cash paid for interest 4,725,000 1,122,000 [1] 1,178,000 [1]
Cash paid for taxes, net of refund 18,508,000 19,128,000 [1] 15,667,000 [1]
Assets acquired under capital lease $ 277,000 $ 301,000 [1] $ 334,000 [1]
[1] Adjusted pursuant to adoption of ASU 2016-18, Statements of Cash Flows, Restricted Cash. Refer to Note 8 and Note 27 to the consolidated financial statements.
[2] Adjusted pursuant to adoption of ASU No. 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Post-retirement Benefit Cost. Refer to Note 21 and Note 27 to the consolidated financial statements.